United States · FDA National Drug Code directory
SUMATRIPTAN SUCCINATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-656_16b7e44d-afa0-4177-80ef-c3ae9a78a4e1
- Product NDC
- 46708-656
- Form
- INJECTION
- Composition / generic term
- sumatriptan succinate
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251106
- Source listing expiry
- 20261231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 4 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (46708-656-01) / .5 mL in 1 SYRINGE · 46708-656-01
- 1 SYRINGE in 1 CARTON (46708-656-05) / .5 mL in 1 SYRINGE · 46708-656-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →